"The
Report Corneal Neovascularization - Pipeline Review, H1 2016 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
Global
Markets Directs, Corneal Neovascularization - Pipeline Review, H1
2016, provides an overview of the Corneal
Neovascularization
pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Corneal Neovascularization, complete with analysis by
stage of development, drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Corneal Neovascularization and
features dormant and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download Sample copy of this
Report at: http://www.marketresearchreports.biz/sample/sample/726779
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Corneal Neovascularization
-
The report reviews pipeline therapeutics for Corneal
Neovascularization by companies and universities/research institutes
based on information derived from
company
and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Corneal Neovascularization
therapeutics and enlists all their major and minor projects
-
The report assesses Corneal Neovascularization therapeutics based on
drug target, mechanism of action (MoA), route of administration (RoA)
and molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Corneal Neovascularization
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Corneal Neovascularization
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Corneal Neovascularization pipeline depth and focus of Indication
therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Read
our latest Press Release at
http://www.marketresearchreports.biz/pressreleases
Table Of Content
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report
Coverage 5
Corneal Neovascularization
Overview 6
Therapeutics Development 7
Pipeline Products for Corneal
Neovascularization - Overview 7
Pipeline Products for Corneal
Neovascularization - Comparative Analysis 8
Corneal Neovascularization -
Therapeutics under Development by Companies 9
Corneal Neovascularization -
Therapeutics under Investigation by Universities/Institutes 10
Corneal Neovascularization -
Pipeline Products Glance 11
Late Stage Products 11
Early Stage Products 12
Corneal Neovascularization -
Products under Development by Companies 13
Corneal Neovascularization -
Products under Investigation by Universities/Institutes 14
Corneal Neovascularization -
Companies Involved in Therapeutics Development 15
Amakem NV 15
Gene Signal International SA 16
Sirnaomics, Inc. 17
Corneal Neovascularization -
Therapeutics Assessment 18
Assessment by Monotherapy
Products 18
Assessment by Target 19
Assessment by Mechanism of
Action 21
Assessment by Route of
Administration 23
Assessment by Molecule Type 25
Drug Profiles 27
aganirsen - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
AMA-0526 - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Gene Therapy to Activate
Raver-2 Protein for Corneal Neovascularization - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Gene Therapy to Inhibit
Vascular Endothelial Growth Factor A for Corneal
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment